1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with sulfinpyrazone in 6 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (sulfinpyrazone) | Trials (sulfinpyrazone) | Recent Studies (post-2010) (sulfinpyrazone) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 1,122 | 172 | 32 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | sulfinpyrazone (IC50) |
|---|---|---|---|
| fMet-Leu-Phe receptor | Homo sapiens (human) | 14.4 | |
| fMet-Leu-Phe receptor | Homo sapiens (human) | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| FitzGerald, GA; Pedersen, AK | 1 |
| O'Flaherty, JT; Stimler, NP | 1 |
| Chignard, M; Lefort, J; Vargaftig, BB; Wal, F | 1 |
| Benveniste, J; Chignard, M; Lefort, J; Vargaftig, BB; Wal, F | 1 |
| Chignard, M; Lefort, J; Medeiros, MC; Vargaftig, BB; Wal, F | 1 |
| Kelefiotis, D; Vakirtzi-Lemonias, C | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and sulfinpyrazone
| Article | Year |
|---|---|
Background and present status of research on platelet-activating factor (PAF-acether).
Topics: Animals; Basophils; Blood Platelets; Chromatography, Thin Layer; Dogs; Guinea Pigs; Humans; Leukocytes; Lipase; Lysophosphatidylcholines; Macrophages; Neutrophils; Phospholipases A; Platelet Activating Factor; Platelet Aggregation; Rabbits; Rats; Sulfinpyrazone | 1981 |
5 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and sulfinpyrazone
| Article | Year |
|---|---|
Cyclooxygenase inhibition, platelet function, and metabolite formation during chronic sulfinpyrazone dosing.
Topics: Adult; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Cyclooxygenase Inhibitors; Epoprostenol; Humans; Platelet Activating Factor; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Sulfinpyrazone; Thromboxane B2 | 1985 |
Spasmogenic properties of platelet-activating factor: evidence for a direct mechanism in the contractile response of pulmonary tissues.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Aspirin; Blood Platelets; Catechols; Chromones; Dose-Response Relationship, Drug; Guinea Pigs; Indomethacin; Lung; Masoprocol; Muscle Contraction; Muscle, Smooth; Platelet Activating Factor; Rats; Sulfinpyrazone; Thromboxane B2 | 1983 |
Inhibition by sulphinpyrazone of the platelet-dependent bronchoconstriction due to platelet-activating factor (PAF-acether) in the guinea pig.
Topics: Adenosine Diphosphate; Airway Resistance; Animals; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Bronchi; Guinea Pigs; In Vitro Techniques; Lysophosphatidylcholines; Muscle Contraction; Platelet Activating Factor; Platelet Count; Sulfinpyrazone | 1982 |
Pharmacological properties of PAF-acether in the guinea-pig: platelet-dependent and independent reactions.
Topics: Animals; Blood Platelets; Bronchi; Guinea Pigs; Platelet Activating Factor; Platelet Aggregation; Reserpine; Stereoisomerism; Sulfinpyrazone | 1982 |
In vivo responses of mouse blood cells to platelet-activating factor (PAF): role of the mediators of anaphylaxis.
Topics: Anaphylaxis; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Cells; Chlorpromazine; Erythrocyte Count; Histamine Antagonists; Leukocyte Count; Male; Mice; Mice, Inbred Strains; Platelet Activating Factor; Platelet Count; Promethazine; Serotonin Antagonists; Sulfinpyrazone | 1993 |